6 Podcast Episodes
Richard Finn, MD - Getting a Head Start on Maximizing Long-Term Outcomes for Advanced Hepatocellular Carcinoma: The Evolution of First-Line Treatment
Richard Finn, MD - Getting a Head Start on Maximizing Long-Term Outcomes for Advanced Hepatocellular Carcinoma: The Evolution of First-Line Treatment
Please visit answersincme.com/JEB860 to participate, download slides and supporting materials, complete the post test, a... Read more
19 Jul 2022
•
13mins
Richard Finn, MD - Getting a Head Start on Maximizing Long-Term Outcomes for Advanced Hepatocellular Carcinoma: The Evolution of First-Line Treatment
Richard Finn, MD - Getting a Head Start on Maximizing Long-Term Outcomes for Advanced Hepatocellular Carcinoma: The Evolution of First-Line Treatment
Please visit answersincme.com/JEB860 to participate, download slides and supporting materials, complete the post test, a... Read more
19 Jul 2022
•
13mins
Gnar Couch Podcast Episode 22 - Richard Finn Jr. (Rampage Builder)
Gnar Couch Podcast Episode 22 - Richard Finn Jr. (Rampage Builder)
Just like the Gnards, builders never get the credit they deserve. So, this week the boys tip their hats to Richard Finn,... Read more
9 Mar 2021
•
2hr 7mins
The English Dominican Province by Fr Richard Finn OP
The English Dominican Province by Fr Richard Finn OP
26 Fr Richard Finn OP, a member of the Dominican house in Oxford, gives a lucid and informative account of the establish... Read more
10 Oct 2017
•
46mins
Results of a randomised phase 2 study of PD 0332991: Dr Richard Finn - Universtity of California, Los Angeles, USA
Results of a randomised phase 2 study of PD 0332991: Dr Richard Finn - Universtity of California, Los Angeles, USA
Dr Richard Finn talks to ecancer at SABCS 2012 about the cyclin-dependent kinase 4/6 inhibitor, in combination with letr... Read more
18 Dec 2012
•
7mins
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer: Prof Richard Finn - Universtity of California
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer: Prof Richard Finn - Universtity of California
Prof Finn talks to ecancer at at the IMProving care And Knowledge through Translational research (IMPAKT) meeting in Bru... Read more
29 May 2012
•
7mins